TrialJournal for immunotherapy of cancer2024

Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies.

Joe Y Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.